Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Mats WahlstromDirector | Coherus OncologyCHRS | Open-market sale | 25/05/23 | 25/05/28 | 99,988 sh | $0.74 | $73,991.12 | −100.0% |
Dennis M. LanfearPresident & CEO | Coherus OncologyCHRS | Open-market sale | 23/11/22 | 23/11/24 | 223,100 sh | $2.02 | $450,662 | −23.4% |